Related Experiment Video
Updated: Jul 6, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
DMGL-MDA: A dual-modal graph learning method for microbe-drug association prediction
Bei Zhu1, Hao-Yang Yu1, Bing-Xue Du1
1School of Life Sciences, Northwestern Polytechnical University, Xi'an 710072, China.
Identifying microbe-drug associations (MDAs) is vital for drug safety. A new computational model, dual-modal graph learning for microbe-drug association prediction (DMGL-MDA), offers a superior, cost-effective method for predicting these crucial interactions.
Area of Science:
- Microbiology
- Pharmacology
- Computational Biology
Background:
- Microbe-drug interactions significantly influence human health.
- Predicting microbe-drug associations (MDAs) is essential for safe drug administration.
- Traditional experimental methods for MDA prediction are costly and time-consuming.
Purpose of the Study:
- To develop a novel computational approach for efficient and accurate prediction of microbe-drug associations (MDAs).
- To overcome limitations of existing graph neural network (GNN) models, such as over-smoothing and over-squashing, and issues with similarity matrix dependency.
Main Methods:
- Proposed a novel graph representation learning model named dual-modal graph learning for microbe-drug association prediction (DMGL-MDA).
- DMGL-MDA incorporates a dual-modal embedding module, a bipartite graph network embedding module, and a predictor module.
- Evaluated DMGL-MDA against state-of-the-art methods on two benchmark datasets using cross-validation.
Main Results:
- DMGL-MDA demonstrated superior performance compared to existing methods.
- Cross-validation confirmed the effectiveness of the proposed model.
- Ablation experiments and case studies further validated the model's predictive capabilities.
Conclusions:
- DMGL-MDA provides a robust and efficient computational solution for predicting microbe-drug associations.
- The model addresses key challenges in existing GNN-based approaches, offering improved accuracy and reliability.
- This work facilitates low-cost, high-throughput screening of potential MDAs, aiding drug development and personalized medicine.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

